According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives. In most cases, it is treatable, yet there are some cases where all known therapies are met with resistance and things take a turn for the worse. However, a new study involving mouse models revealed that a precursor to vitamin K can potentially slow prostate cancer growth.
Groundbreaking Study on Vitamin K and Cancer
researchers in a lab
Credit: Pexels
A recent discovery at Cold Spring Harbor Laboratory potentially offers a novel solution to the prostate cancer issue. Professor Lloyd Trotman and his team have discovered that the pro-oxidant supplement menadione reduces the development of prostate cancer in studies involving mice. Menadione is found in leafy greens and is a precursor to vitamin K. While this study itself is new, it is the result of another study that took place at the beginning of this century.
ADVERTISEMENT
How To Make Sauerkraut Caserole
Chicken Alfredo Stuffed Shells Casserole
How To Make FIDEO CON CARNE AND PAPAS
Can You Spot the Hidden Animals
Greek-style Tuna Salad
Unbelievable! It’s a painkiller! Eliminates pain like an eraser!
’ve rediscovered a recipe that’s pure nostalgia! My grandma used to make these for holiday parties
Put This on Your Pots or Pans and They Will Be Like New – Active Yeast!
You’ll never see mosquitoes again if you do this
